Skip to search formSkip to main contentSkip to account menu

agalsidase alfa

Known as: recombinant alpha-galactosidase A 
National Institutes of Health

Related topics

Related topics

3 relations

Broader (2)

ALPHA-D-GALACTOSIDASE ENZYMEIsoenzymes

Narrower (1)

Replagal

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Efficacy and safety of enzyme-replacement-therapy with agalsidase alfa in 36 treatment-naïve Fabry disease patients
Fabry disease (FD) is an X-linked lysosomal storage disorder resulting from the α-galactosidase A gene mutations. Enzyme… 
Review
2017
Review
2017
A comparison of central nervous system involvement in patients with classical Fabry disease or the later-onset subtype with the IVS4+919G>A mutation
BackgroundPatients with the later-onset IVS4+919G>A (IVS4) Fabry mutation are known to have positive central nervous system… 
Review
2016
Review
2016
Fabry in the older patient: Clinical consequences and possibilities for treatment.
Review
2015
Review
2015
Fabry disease: a review of current enzyme replacement strategies
Introduction: Fabry disease (OMIM 301500) is an X linked lysosomal storage disorder caused by deficiency of α galactosidase A… 
2012
2012
Effects of enzyme replacement therapy in adult patients with Fabry disease on cardiac structure and function: a retrospective cohort study of the Fabry Münster Study (FaMüS) data
Objective Fabry disease (FD) is an X-linked inborn error of glycosphingolipid catabolism caused by deficient lysosomal… 
2010
2010
Enzymersatztherapie bei Morbus Fabry
ZusammenfassungDer Morbus Fabry ist die einzige lysosomale Speicherkrankheit, bei welcher 2 verschiedene Präparate (Agalsidase… 
2007
2007
Agalsidase alfa (Replagal™) in the treatment of Anderson-Fabry disease
  • G. Pastores
  • Biologics : targets & therapy
  • 2007
  • Corpus ID: 17351645
Anderson-Fabry disease (AFD) is an X-linked storage disorder caused by a deficiency of the lysosomal hydrolase a-galactosidase A… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)